<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03605628</url>
  </required_header>
  <id_info>
    <org_study_id>NMB Abdomen</org_study_id>
    <nct_id>NCT03605628</nct_id>
  </id_info>
  <brief_title>Influence of Analgesia and Neuromuscular Block on Abdominal Distension and Operating Conditions Laparoscopic Operations</brief_title>
  <official_title>Influence of Analgesia and Neuromuscular Block on Abdominal Distension and Operating Conditions During Gynecologic Laparoscopic Operations</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kreiskrankenhaus Dormagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kreiskrankenhaus Dormagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neuromuscular block improves operation conditions during laparoscopic surgery. In this study,
      a new measurement tool is assessed: the degree of abdominal distension during the time course
      of the neuromuscular block is measured and compared with a standardized score (surgical
      rating score).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">July 1, 2018</start_date>
  <completion_date type="Anticipated">June 30, 2019</completion_date>
  <primary_completion_date type="Anticipated">June 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>Assessment of the quality of operation conditions by the obstretic surgeon without information with regard to the actual depth of the neuromuscular block or the drugs administrated for improvement of the block.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>change in abdominal wall length (cm) during time course of the block</measure>
    <time_frame>during operation</time_frame>
    <description>Changes in abdominal wall length are measured during the time course of the neuromuscular block every 15 min.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change of surgical Rating scale (SRS) scores during neuromuscular block</measure>
    <time_frame>during operation</time_frame>
    <description>assessment of operating conditions by means of a standardized score: surgical rating score (Martini et al. Evaluation of surgical conditions during laparoscopic surgery in patients with moderate vs. deep neuromuscular block. Br J Anaesth 2014; 112: 498-505:
extremely poor conditions
poor conditions
acceptable conditions
good conditions
optimal conditions
The surgical rating score is assessed every 15 min together with abdominal wall length and depth of neuromuscular block</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>changes of abdominal distension or surgical Rating score (SRS) induced by additional analgesics, sedatives or neuromuscular blocking agents</measure>
    <time_frame>during operation</time_frame>
    <description>If a bolus of an analgesic, sedative or neuromuscular blocking agent is required because of inadequate anesthesia during the operation, all measurements mentioned above are performed immediately after the injection of the drug in order to assess the effect of the bolus injection.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Neuromuscular Blockade</condition>
  <arm_group>
    <arm_group_label>abdominal wall length</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Measurement of abdominal wall length during neuromuscular block with a measuring tape</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>measuring tape</intervention_name>
    <description>measurement of change in abdominal wall length [cm] during neuromuscular block with a measuring tape.</description>
    <arm_group_label>abdominal wall length</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>neuromuscular block</intervention_name>
    <description>Measurement of the time course of the neuromuscular block: neuromuscular transmission is measured by assessment of the post tetanic count and the train of four ratio using acceleromyography (TOF Watch SXâ„¢, Essex Pharma GmbH, Munich, Germany) at the right adductor pollicis muscle with transcutaneous Ag/AgCl electrodes (electrocardiogram electrodes; Ambu Inc., MD 21060 USA);</description>
    <arm_group_label>abdominal wall length</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Surgical rating score</intervention_name>
    <description>assessment of operating conditions by means of a standardized score: surgical rating score:
extremely poor conditions
poor conditions
acceptable conditions
good conditions
optimal conditions</description>
    <arm_group_label>abdominal wall length</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  laparoscopic gynecologic surgery

          -  body weight 50-90 kg

          -  American Society of Anesthesiologists Physical Status ASA 1-2

        Exclusion Criteria:

          -  anticipated difficult airway

          -  increased risk for pulmonary aspiration

          -  acute infection

          -  pregnancy

          -  impaired liver- oder kidney function

          -  neuromuscular disease

          -  chronic intake of drugs known to influence neuromuscular blockade
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stefan Soltesz, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kreiskrankenhaus Dormagen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stefan Soltesz</last_name>
    <phone>0049 2133 66 4500</phone>
    <email>stefan.soltesz@kkh-ne.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kreiskrankenhaus Dormagen</name>
      <address>
        <city>Dormagen</city>
        <zip>D-51375</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stefan Soltesz, MD</last_name>
      <email>stefan.soltesz@kkh-ne.de</email>
    </contact>
    <investigator>
      <last_name>Stefan Soltesz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>April 12, 2018</study_first_submitted>
  <study_first_submitted_qc>July 21, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2018</study_first_posted>
  <last_update_submitted>July 21, 2018</last_update_submitted>
  <last_update_submitted_qc>July 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 30, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

